What is PTIX's current stock price?

PTIX (Protagenic Therapeutics, Inc.) is currently trading at $0.62 with a market cap of $1.1M.

What sector is Protagenic Therapeutics, Inc. in?

Protagenic Therapeutics, Inc. (PTIX) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

PTIX Protagenic Therapeutics, Inc.

Healthcare

$0.62+0.00%ClosedMarket Cap: $1.1M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

-0.50

P/S

0.00

EV/EBITDA

-0.26

DCF Value

$-1.43

FCF Yield

-370.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

184.9%

ROA

-241.8%

ROIC

379.7%

Financials

View All

Period	Revenue	Net Income	EPS
Q4 null	$0.00	$2.2M	$—
FY null	$0.00	$-5.2M	$—
Q3 null	$0.00	$-869.5K	$—
Q2 null	$0.00	$-5.1M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

EVANS BARRETTdirector, 10 percent owner, officer: ex CEO

SellFri Oct 24

WRIGHT TIMOTHY Rdirector

SellMon Apr 01

Stein Robert Benjamindirector

SellFri Mar 29

Buell Jenniferdirector

SellFri Mar 29

Barrage Khalildirector

SellFri Mar 29

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

0.47

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.

Peers

PBM